nternational Murex Technologies of Toronto said Friday it willconsolidate Murex Biologicals Inc. and Dominion BiologicalsLtd., its blood bank reagent subsidiaries, as part of areorganization.
MBI of Conroe, Texas will be closed and its product licensestransferred to Dominion in Dartmouth, Nova Scotia. Nointerruption in supply or sales of FDA-licensed product isanticipated.
The reorganization is expected to cost $800,000 during 1993.It is part of a continuing effort by International Murex toreduce costs and improve managerial control, the companysaid.
(c) 1997 American Health Consultants. All rights reserved.